BTS & Partners has advised Eczacibasi Momentum on its USD 12 million Series A Round investment in RS Research.
The investment round was led by Gen Ilac with the participation of One Life Ventures.
Founded in 2015, RS Research is a clinical-stage biotechnology start-up developing nanomedicines based on drug delivery platform Sagitta for targeted chemotherapy.
BTS & Partners did not respond to our inquiry on the matter.
